Ctd-L 6.25/50Mg 10 Tablets

babies: not recommended. lactating mothers: may or may not be safe if prescribed.
please consult your doctor. pregnancy: may or may not be safe if prescribed. please consult your doctor. driving: may be unsafe as it may alters the concentration by making you feel sleepy and dizzy. alcohol: highly unsafe as it may worsen the state of drowsiness. kidney: dose adjustment may require in kidney impaired patients.
please consult your doctor. liver: dose adjustment may require in hepatic impaired patients. please consult your doctor..

Dizziness Headache Drowsiness Nausea Stomach upset Tiredness Palpitations Glucose intolerance Increased blood uric acid Taste changes Electrolyte imbalance.

CTD L tablets are given in combination with two antihypertensive agents to manage high blood pressure, which helps control the blood pressure, thereby reducing the risk of heart attacks or stroke. It is a combination of two medicines, each of which provides effective actions individually by removing extra water and salt (sodium chloride) and blocking the action of angiotensin ii hormone that effectively relaxes the blood vessels, which eases the blood flow and helps the heart to pump efficiently..

If you miss a dose, Take it as soon as possible. If It is near the time of the next dose, then skip the missed dose.
Take the prescribed dose on your regular time daily. Don't double the dose to catch up with the missed dose..

• This tablet is prescribed to treat and manage high blood pressure, reducing the risk of heart attacks or stroke. • This tablet may cause dizziness; hence, It is advised to Get up slowly when sitting or lying.
• Dehydration may be caused due to This medication. You need to Drink plenty of water while on This medication to stay hydrated.
• Take this medication four hours Before bedtime as It contains a water pill which will make you urinate frequently..

• chlorthalidone + benazepril: either increases toxicity of others by pharmacodynamic synergism. enhances the hypotensive effect.
increased risk of nephrotoxicity. • chlorthalidone + digoxin: chlorthalidone increases the effect of digoxin by pharmacodynamic synergism.
risk of hypokalemia. • losartan potassium + acebutolol: both increases serum potassium levels when given together.
• losartan potassium + enalapril: co-administration may increase the risks of hypotension, hyperkalemia and renal impairment due to dual blockade of the renin-angiotensin system. either increase the toxicity of others by pharmacodynamic synergism..